(VRNA) |
| 0 (0%) 10-10 16:19 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 124.89 |
| Resistance 1: | 106.93 |
| Pivot price: | 106.56 |
| Support 1: | 106.22 |
| Support 2: | 105.78 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -1.040 |
| Book Value | 3.240 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.482 |
| Profit Margin (%) | -36.63 |
| Operating Margin (%) | 12.90 |
| Return on Assets (ttm) | -6.7 |
| Return on Equity (ttm) | -36.4 |
Company news
Fri, 10 Oct 2025
Can volume confirm reversal in VRNA - Portfolio Value Report & Accurate Trade Setup Notifications - newser.com
Thu, 09 Oct 2025
Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Wed, 08 Oct 2025
VRNA: Cantor Fitzgerald Maintains Overweight Rating with $100 PT | VRNA Stock News - GuruFocus
Wed, 08 Oct 2025
New Analyst Forecast: $VRNA Given $100.0 Price Target - Quiver Quantitative
Wed, 08 Oct 2025
Verona Pharma plc (VRNA)’s Shareholders Authorizes the $10 Billion Acquisition of Verona Pharma plc (VRNA); Nasdaq Trading to Suspend - Yahoo Finance
Tue, 07 Oct 2025
Merck completes acquisition of Verona Pharma; VRNA shares delisted from Nasdaq - Investing.com
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
